PARP1 and pseudoxanthoma elasticum (inherited or acquired): Another therapeutic option investigated as an anti-calcification agent in PXE models is minocycline, an inhibitor of poly-ADP ribose polymerase 1 (PARP1), a pivotal member of the DNA damage response (DDR).